Peter Lange
Direktor/Vorstandsmitglied bei Technical University of Berlin
Profil
Peter Lange is currently the Vice Chairman at the Technical University of Berlin and a Member-Supervisory Board at Vakzine Projekt Management GmbH since 2012.
He previously worked as a Lecturer at Eberhard Karls Universität Tübingen in 1994.
Dr. Lange has an undergraduate degree from the University of Gottingen and a doctorate degree from Eberhard Karls Universität Tübingen.
Aktive Positionen von Peter Lange
| Unternehmen | Position | Beginn |
|---|---|---|
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Corporate Officer/Principal | - |
| Technical University of Berlin | Direktor/Vorstandsmitglied | 16.11.2009 |
Ehemalige bekannte Positionen von Peter Lange
| Unternehmen | Position | Ende |
|---|---|---|
| Eberhard Karls Universität Tübingen | Corporate Officer/Principal | 01.01.1994 |
Ausbildung von Peter Lange
| University of Gottingen | Undergraduate Degree |
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
